| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers C > Headlines for Cardiome Pharma Corp. > News item |
Cardiome extends expiration of Dutch auction tender offer to Oct. 6
By Lisa Kerner
Charlotte, N.C., Sept. 25 - Cardiome Pharma Corp. extended its modified Dutch auction tender offer to 5 p.m. ET on Oct. 13 from 5 p.m. ET on Oct. 6.
The offer began on Sept. 1.
According to Cardiome, it extended the offer in order to include additional information in its offer about the development strategy for GED-aPC and the transition of its chief medical officer, Dr. Charles Fisher, to a consulting role.
Cardiome, a Vancouver, B.C., cardiovascular drug-development company, will purchase up to 6,470,588 of its common shares for a total of up to $27.5 million in the offer.
As previously reported, the shares will be bought at a price of between $4.25 and $5.10 each.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.